Cervical Cancer Human Cervix Total RNA, Donor 1433 (CAT#: DBFF-0624-HY4564)

Datasheet

Overview

Cervical cancer is a disease caused by human papillomavirus (HPV) infection that causes cell mutations at the cervical site that eventually lead to malignant tumors. Cervical Cancer Human Cervix Total RNA, Donor 1433 is extracted from cervix tissue of a single cervical cancer human donor using a classical guanidine isothiocyanate-phenol: chloroform extraction method. RNA goes through rigorous quality control procedures to ensure the highest quality possible.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Female

Age At Sampling

35 yrs

Race

White or Caucasian

Medical Diagnosis

Adenocarcinoma of cervix, endometrioid

Product Description

Species

Human

Tissue Name

Cervix

Sample Diagnosis Category

Cervical Cancer

28S/18S Ratio

1.47

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Northern blotting, ribonuclease protection assay, polymerase chain reaction analysis, rapid amplification of cDNA end analysis, cDNA synthesis, RNA differential display, microRNA studies, and RNA library construction.

Product Properties

Normal Ratio

Lesional Ratio

Tumor Ratio

45%

Hypocellular/Acellular Tumor Stroma Ratio

50%

Hypercellular Tumor Stroma Ratio

Necrosis Ratio

H&E Staining Pathological Verification

Tumor stroma: prominent mixed lympho-plasmacytic and neutrophilic infiltrate

Histopathological Grade

FIGO G1: Well differentiated

Tumor Stage

IB1

Primary Tumor (T)

T1b1

Regional Lymph Node (N)

Distant Metastasis (M)

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use